Cargando…

Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array

PURPOSE: To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin. METHODS: DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Zhi, Bal, Suzanne M., Romeijn, Stefan, Kersten, Gideon F. A., Jiskoot, Wim, Bouwstra, Joke A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003783/ https://www.ncbi.nlm.nih.gov/pubmed/20237826 http://dx.doi.org/10.1007/s11095-010-0093-y

Ejemplares similares

Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations
por: Bal, Suzanne M., et al.
Publicado: (2010)

Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles
por: Du, Guangsheng, et al.
Publicado: (2018)

Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment
por: Ding, Z., et al.
Publicado: (2009)

Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
por: van der Maaden, Koen, et al.
Publicado: (2015)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Common Reference-Based Tandem Mass Tag Multiplexing for the Relative Quantification of Peptides: Design and Application to Degradome Analysis of Diphtheria Toxoid
por: Michiels, Thomas J. M., et al.
Publicado: (2021)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery
por: Tu, Jing, et al.
Publicado: (2017)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Engineered microneedle arrays for transcutaneous HIV vaccine delivery
por: DeMuth, P, et al.
Publicado: (2012)

Investigating preparation and characterisation of diphtheria toxoid‐loaded on sodium alginate nanoparticles
por: Aghamiri, Samira, et al.
Publicado: (2022)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

Dissolving Microneedle Patches for Dermal Vaccination
por: Leone, M., et al.
Publicado: (2017)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

Cellobiose-coated poly (lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization
por: Chudina, Tetiana, et al.
Publicado: (2015)

Universal Applicator for Digitally-Controlled Pressing Force and Impact Velocity Insertion of Microneedles into Skin
por: Leone, Mara, et al.
Publicado: (2018)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
por: Castillo, Sonsire Fernández, et al.
Publicado: (2016)

Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland
por: Zasada, Aleksandra A, et al.
Publicado: (2013)

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
por: Myers, Tanya, et al.
Publicado: (2018)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Levothyroxine sodium loaded dissolving microneedle arrays for transdermal delivery
por: Ghazi, Riyam F., et al.
Publicado: (2022)

Fabrication of Black Silicon Microneedle Arrays for High Drug Loading
por: Cheng, Wei, et al.
Publicado: (2023)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model
por: Zare Banadkoki, Ehsan, et al.
Publicado: (2022)

Towards Heat-stable Oxytocin Formulations: Analysis of Degradation Kinetics and Identification of Degradation Products
por: Hawe, Andrea, et al.
Publicado: (2009)

Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial
por: Jacobse, Justin, et al.
Publicado: (2021)

Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
por: Barnier-Quer, Christophe, et al.
Publicado: (2013)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018)

CELLULAR SITES OF SYNTHESIS OF RABBIT IMMUNOGLOBULINS DURING PRIMARY RESPONSE TO DIPHTHERIA TOXOID-FREUND'S ADJUVANT
por: Schoenberg, M. D., et al.
Publicado: (1965)

Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity
por: Najafzadeh, Faezeh, et al.
Publicado: (2015)

Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid
por: Najafzadeh, Faezeh, et al.
Publicado: (2014)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Hoffmeister Series Ions Protect Diphtheria Toxoid from Structural Damages at Solvent/Water Interface
por: Namur, Jocimara A.M., et al.
Publicado: (2009)

Antigen Uptake After Intradermal Microinjection Depends on Antigen Nature and Formulation, but Not on Injection Depth
por: Leboux, Romain J. T., et al.
Publicado: (2021)

Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery
por: Ono, Akihiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c987bp2q69gbdk80l6vn981ogk